$157.87-5.18 (-3.18%)
The Ensign Group, Inc.
The Ensign Group, Inc. in the Healthcare sector is trading at $157.87 with a market capitalization of $9.2B. Wall Street consensus targets $220.40 (5 analysts), implying a +39.6% move over the next 12 months. The stock is currently 28% below its 52-week high of $218.00, remaining 13.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.39B↑ | $1.36B↑ | $1.30B↑ | $1.23B↑ | $1.17B |
| Gross Profit | $227.86M↑ | $222.32M↑ | $190.22M↓ | $198.79M↑ | $188.12M |
| Operating Income | $124.85M↑ | $123.81M↑ | $96.22M↓ | $103.90M↑ | $101.37M |
| Net Income | $99.67M↑ | $95.45M↑ | $83.84M↓ | $84.40M↑ | $80.28M |
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for p...
Ensign Group is accelerating growth through acquisitions and operational gains, with record occupancy, rising revenue and capital ready for more deals.
Ensign Group boosts buyback capacity to $100M after strong Q1 2026 results, rising cash flow and higher earnings guidance signal confidence.
The Ensign Group Inc. (NASDAQ:ENSG) is one of the most promising mid-cap stocks to buy according to analysts. On June 2, Ensign announced the acquisition of real estate and operations for Woodland Health and Rehabilitation, a 62-bed skilled nursing facility in Mount Pleasant, Iowa. The transaction was completed through Ensign-affiliated entities, with the real estate […]
Ensign Group is riding on rising occupancy, acquisitions and real estate growth, with strong cash flow and low debt supporting long-term expansion.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.